These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7658998)

  • 1. [Non alcoholic steatohepatitis].
    Manero E; Findor JA; Avagnina A; de Elizalde S; Elsner B
    Medicina (B Aires); 1994; 54(6):625-9. PubMed ID: 7658998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
    Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
    Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis.
    Tsang SW; Ng WF; Wu BP; Chow DA; Li ET; Wong TC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):116-21. PubMed ID: 16706822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
    Dixon JB; Bhathal PS; O'Brien PE
    Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
    Satapathy SK; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2007 May; 22(5):634-8. PubMed ID: 17444848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.
    Solis-Herruzo JA; Pérez-Carreras M; Rivas E; Fernández-Vázquez I; Garfia C; Bernardos E; Castellano G; Colina F
    Am J Gastroenterol; 2005 May; 100(5):1091-8. PubMed ID: 15842583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
    Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
    Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
    Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver.
    Loguercio C; De Simone T; D'Auria MV; de Sio I; Federico A; Tuccillo C; Abbatecola AM; Del Vecchio Blanco C;
    Dig Liver Dis; 2004 Jun; 36(6):398-405. PubMed ID: 15248380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
    Keshishian A; Zahriya K; Willes EB
    Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.